Moreover, the downregulation of PD-1/PD-L1 axis by immunotherapy appears to cause an upregulation of TIM-3 expression on T cells, resulting in inadequate treatment responses and immunological escape of the tumor [22]. The gene discussed is HAVCR2; the disease is neoplasm.